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Diabetic Rats Without Changes
in Incretins or Insulin Secretion
Gastric bypass surgery can dramatically improve
type 2 diabetes. It has been hypothesized that by
excluding duodenum and jejunum from nutrient
transit, this procedure may reduce putative signals
from the proximal intestine that negatively influence
insulin sensitivity (SI). To test this hypothesis,
resection or bypass of different intestinal segments
were performed in diabetic Goto-Kakizaki and
Wistar rats. Rats were randomly assigned to five
groups: duodenal-jejunal bypass (DJB), jejunal
resection (jejunectomy), ileal resection (ileectomy),
pair-fed sham-operated, and nonoperated controls.
Oral glucose tolerance test was performed within
2 weeks after surgery. Baseline and poststimulation
levels of glucose, insulin, glucagon-like peptide 1
(GLP-1), and glucose-dependent insulinotropic
polypeptide (GIP) were measured. Minimal model
analysis was used to assess SI. SI improved after
DJB (SI = 1.14 6 0.32 3 10
24 min21 $ pM21) and
jejunectomy (SI = 0.80 6 0.14 3 10
24 min21 $ pM21),
but not after ileectomy or sham operation/pair
feeding in diabetic rats. Both DJB and jejunal
resection normalized SI in diabetic rats as shown by
SI levels equivalent to those of Wistar rats (SI =
1.01 6 0.06 3 1024 min21 $ pM21; P = NS). Glucose
effectiveness did not change after operations in any
group. While ileectomy increased plasma GIP
levels, no changes in GIP or GLP-1 were observed
after DJB and jejunectomy. These findings support
the hypothesis that anatomic alterations of the
proximal small bowel may reduce factors
associated with negative influence on SI, therefore
contributing to the control of diabetes after gastric
bypass surgery.
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Gastric bypass surgery results in rapid and sustained
remission of type 2 diabetes (1,2). Experimental evidence
from both animal (3,4) and human studies (5–7) suggest
that the improvement of diabetes after gastric bypass is
partly independent of weight loss and decreased caloric
intake. Possible weight-independent mechanisms include
changes in gut hormones (8), bile acid metabolism (9),
nutrient sensing (10), and microbiota (11).
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Roux-en Y gastric bypass surgery (RYGB) creates
a complex rearrangement of gastrointestinal anatomy,
involving reduction of the volume of the stomach, bypass
of proximal segments of the small bowel (duodenum and
jejunum), and expedited delivery of nutrients to the
ileum. Such rearrangement of the gastrointestinal anat-
omy is likely to activate more than one mechanism of
action (12). Elucidating the specific role of distinct ana-
tomic alterations imposed by gastric bypass has far-
reaching implications. This knowledge may simplify the
design of future surgical or device-based approaches,
inform pharmaceutical research regarding new targets
for effective antidiabetes drugs, and possibly help eluci-
date the elusive pathophysiology of type 2 diabetes and
other insulin-resistant states.
The substantial weight loss and improvement of di-
abetes after vertical sleeve gastrectomy (12), a procedure
that does not involve rerouting of the small intestine,
support a role of gastric manipulations in the mecha-
nisms of improved metabolism after bariatric surgery.
However, clinical and experimental data from studies of
stomach-sparing procedures, such as duodenal-jejunal
bypass (DJB) (3,4,10,13–15), endoluminal duodenal
sleeve (16,17), ileal-interposition (18,19), jejuno-ileal
bypass (20), and jejunectomy (21), show that these
approaches can improve type 2 diabetes with relatively
minor changes in body weight (22).
Two theories have been proposed to explain how small
bowel manipulations can improve glucose metabolism:
the distal (or hindgut) hypothesis suggests that diabetes
control results from the rapid delivery of nutrient chyme
to the distal intestine, enhancing physiologic signals that
improve glucose metabolism (i.e., increased incretins,
specifically glucagon-like peptide 1 [GLP-1], or increased
intestinal uptake of glucose) (12,18). The proximal (or
foregut) hypothesis suggests that the effect of gastric
bypass on glucose metabolism depends on the exclusion
of duodenum and proximal jejunum from the transit of
nutrients, possibly preventing the secretion of a putative
signal that promotes insulin resistance and type 2 di-
abetes (12,23–25).
In this study, we sought to investigate the role of
the proximal and distal gut on glucose homeostasis by
measuring insulin sensitivity (SI) and incretin (GLP-1 and
glucose-dependent insulinotropic polypeptide [GIP])
levels early after bypass or resection of different seg-
ments of the small intestine.
RESEARCH DESIGN AND METHODS
Animals
A total of 100 male rats aged 10 weeks were used for this
study. Fifty Wistar (normal) and 50 diabetic Goto-
Kakizaki (GK) rats were housed individually in hanging
wire cages. Wistar rats were bred in-house while GK rats
were purchased from Taconic M&B A/S (Tombjerg,
Denmark). Animals were housed in a controlled room at
22°C with a 12-h day/night cycle (lights on at 07:00 and
lights off at 19:00). Rats were allowed to adapt to their
new environment for 4 days before the surgery. Both
Wistar and GK animals randomly underwent DJB, jejunal
resection (jejunectomy), ileal resection (ileectomy), or a
sham operation. Ten animals were originally assigned to
each group. Twenty animals, 10 Wistar and 10 GK rats,
were used as controls. Survival rates after surgery were
90% for sham operations in both strains, 80% for
jejunectomy and ileectomy in both strains, 70% for DJB
in Wistar rats, and 60% for DJB in diabetic animals.
All experimental procedures were approved by the
Catholic University of Rome Institutional Animal Care
Committee.
Interventions
The rats were anesthetized using ketamine (75 mg/kg
intramuscularly) and xylazine (10 mg/kg intramuscularly).
Ten milliliters of sterile 0.9% NaCl was administered s.c.
prior to surgery. Figure 1 summarizes all of the inter-
ventions performed.
DJB
DJB is a stomach-sparing modification of RYGB. Simi-
larly to RYGB, the DJB involves a bypass of the entire
duodenum and the proximal jejunum; the stomach
anatomy, however, is left unperturbed. The procedure
was performed according to the original technique
reported by Rubino and Marescaux and Rubino et al.
(3,4). In brief, the duodenum was divided just distal to
Figure 1—Sketch of the surgical interventions. From left to right: sham, DJB, pre- and postjejunectomy, and pre- and postileectomy.
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the pylorus, and its proximal end was closed using
absorbable suture material. Next, the jejunum was
transected ;10 cm from the ligament of Treitz. The
distal cut end of the jejunum was reconnected to the
stomach through an end-to-end gastrojejunostomy. The
proximal cut end (duodenal-jejunal limb) was recon-
nected to the jejunum at a distance of 15 cm down-
stream of the gastrojejunostomy in an end-to-side
fashion. The resulting anatomy includes the following
intestinal segments: 1) the biliopancreatic limb, con-
sisting of the duodenum and the proximal 10 cm of
jejunum; this limb is excluded from nutrients passage
but continues to carry bile and pancreatic juice; 2) the
alimentary limb (or “Roux limb”), consisting of distal
jejunum; this segment is directly connected to the
stomach and is exposed to nutrients but not to bil-
iopancreatic secretions; and 3) the common channel,
consisting of the entire length of the ileum; this is the
only segment where nutrients and biliopancreatic juices
mix after DJB.
Jejunectomy
The small intestine was measured from the ligament of
Treitz to the ileocecal junction. The proximal 50% of the
intestine was resected. Intestinal continuity was restored
by direct anastomosis between the duodenum and the
remaining ileum.
Ileectomy
Starting from 1 cm proximal to the ileocecal valve,
a segment of 30 cm of distal small bowel (ileum) was
measured and resected. Intestinal continuity was re-
stored by direct anastomosis between the jejunum and
the remaining ileum.
Sham Operation
The sham-operated rats had the same anesthesia as
described above. A midline laparotomy was performed,
and the stomach and intestines were exposed and gently
manipulated. The abdominal cavity was kept open for
the same amount of time required to perform the DJB
procedures in accordance with previous experiments
(3,4). Transection of the gastrointestinal tract was
performed at all sites at which enterotomies were per-
formed for the DJB; the intestinal limbs were then
reanastomosed to allow unaltered progression of food
through the bowel.
Postoperative Care
Postoperative care was identical for all rats as previously
described (26). At the end of the surgical procedures, all
rats received sterile 0.9% NaCl (10 mL i.p. and 10 mL s.c.)
to maintain hydration during healing, since they were
not allowed access to drinking water until the next
morning. All rats received ketoprofen (5 mg/kg) as
analgesics and enrofloxacin (5 mg/kg) as an antibiotic.
The rats were then placed on a heated mat until they
fully recovered from anesthesia, after which they were
returned to their home cages. The rats in the surgical
groups were only allowed to drink purified water for 12 h
after surgery. A liquid diet containing 5% glucose and
0.2% KCl was provided for the next 48 h. The rats were
then fed with standard chow for the remaining of the
study period.
Body Weight and Food Intake
Body weight and food intake were measured daily for the
duration of the study. Wistar and GK sham-operated rats
were pair fed to the animals having intestinal resection
and DJB in order to control for the effect of reduced
calorie intake on SI.
Oral Glucose Tolerance Test
After an overnight fast, blood glucose was measured in
conscious rats before (baseline) and at 15, 30, 60, 90, and
120 min after administration of 2 g/kg glucose by oral
gavage. Blood was obtained in heparinized and aprotinin-
treated tubes (10 ml DPP-4 inhibitor/mL of blood;
Millipore, St. Charles, MO) from a tail vein at each
sampling point to measure insulin and incretins.
Outcome Measures
Glucose was measured using a glucometer (OneTouch
Ultra; LifeScan, Inc., Johnson & Johnson, Milpitas, CA).
Plasma insulin was determined using an ultrasensitive
rat insulin enzyme-linked immunosorbent assay kit
(DRG Diagnostics, Marburg, Germany): intra-assay co-
efficient of variation (CV) was 2.9%, and interassay CV
was 4.8%. Plasma GIP was measured by an enzyme im-
munosorbent assay kit (Phoenix Pharmaceutical Inc.,
Burlingame, CA): sensitivity (minimum detectable con-
centration) 0.44 ng/ml, intra-assay CV 5–10%, and
interassay CV ,15%. Active (7,36)amide plasma GLP-1
was assessed by an enzyme immunosorbent assay kit
(ALPCO Diagnostics, Salem, NH): intra-assay CV
5.36–6.60%, and interassay CV 5.51–18.87%.
Homeostatic Model Assessment of Insulin Resistance
The homeostatic model assessment of insulin resistance
(HOMA-IR) index (27) was calculated as HOMA-IR =
(FBG 3 FPI)/405, where FBG denotes fasting blood
glucose (mg/dL) and FPI is fasting plasma insulin (mU/mL).
The factor 405 accounts for measurement units.
Matsuda-DeFronzo Index
The Matsuda-DeFronzo (composite) SI index (CISI) (28),
estimated from the oral glucose tolerance test (OGTT)
and validated by Carr et al. (29) in the rat was calculated
as follows: CISI = 10,000/(FBG 3 FPI 3 MG 3 MI)1/2,
where MG and MI denote the mean glucose and mean
insulin concentrations, respectively, during the course of
the OGTT (area under the curve [AUC]/120 min). The
factor 10,000 is an arbitrary scaling constant.
Mathematical Model for Measurement of SI
The glucose minimal model (30) was used to analyze
the OGTT data, as it provides a reliable estimate of SI
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that correlates with the euglycemic hyperinsulinemic
clamp. The minimal model is currently used to assess
SI (min
21 $ pM21) and glucose effectiveness (SG; min
21)
from the intravenous and OGTT in humans and has been
validated in mice (31,32).
Minimal model equations were:
_G ¼ 2ðSG þ SIZÞGþ SGGb þ RaVG; Gð0Þ ¼ Gb ð1Þ
_Z ¼ pð2Zþ I2 IbÞ; Zð0Þ ¼ 0 ð2Þ
with




where the overdot means d/dt, G is the glucose concen-
tration (basal value Gb, and DG = G 2 Gb), I is the insulin
concentration (basal value Ib), Z is a variable related to
insulin action, Ra is the rate of appearance of oral glucose
in plasma, VG the glucose distribution volume, and p
a parameter (min21) that represents the rate constant of
the remote insulin compartment from which insulin acts
on glucose disposal.
The model parameters SG, SI, p, a(bVG)
21, and (bVG)
21
were estimated by fitting glucose concentration data.
Direct estimation of the population parameters was
obtained by the NONMEM method (33).
Data Presentation and Statistics
Data are presented as means 6 SD unless otherwise in-
dicated. The AUC was calculated using the trapezoidal
rule. One-factor ANOVA and the ANOVA for repeated
measurements followed by Tukey test were used for in-
tergroup comparisons. The minimal model SI was
regressed against the Matsuda-DeFronzo CISI to verify
the agreement between the two methods. P values ,0.05
were considered significant.
RESULTS
All operated animals lost weight (Fig. 2A) and ate less
food (Fig. 2B) compared with nonoperated controls;
however, no significant differences among the surgical
groups (pair-fed sham, ileectomy, DJB, and jejunectomy)
were observed.
Table 1 reports the incremental AUCs of glucose, as
well as the insulin resistance index HOMA-IR and the
Matsuda-DeFronzo CISI. Among normal rats (Wistar),
the incremental glucose AUC was significantly higher in
the DJB group and lower in the jejunectomy group (P ,
0.001) compared with sham-operated controls. Ileectomy
increased HOMA-IR and decreased CISI versus sham
(P , 0.001). In diabetic rats (GK), DJB significantly de-
creased (P , 0.05) the incremental glucose AUC com-
pared with sham-operated animals. Both jejunectomy
and DJB decreased HOMA-IR (P , 0.001 and P , 0.025,
respectively)and increased CISI (P , 0.001) compared
with sham-operated controls.
The best fit of OGTT plasma glucose levels, obtained
by the oral glucose minimal model, is shown in Fig. 3A
for Wistar rats and in Fig. 3B for GK rats. Sham
operation was associated with an increase in fasting
and postprandial plasma glucose levels (FBG and MG
values) in both normal and diabetic rats. Animals that
underwent jejunectomy showed significantly lower
plasma glucose excursion compared with pair-fed sham
controls in Wistar rats. A similar effect was induced
by DJB in diabetic rats but not in normal rats
(Table 1).
As expected, SI was lower in diabetic rats (0.40 6
0.113 1024) compared with normal rats (1.346 0.203
1024 min21 $ pM21; P , 0.0001) (Table 2). Ten days
after surgery, glucose tolerance worsened in sham-
operated nondiabetic rats, possibly as an effect of the
surgical stress as previously observed in the same rat
model (17). Remarkably, DJB (P , 0.001) improved SI in
diabetic GK rats, resulting in levels of SI that were similar
to those of nondiabetic, sham-operated Wistar rats.
A trend for improved SI (albeit not statistically significant)
was also observed after jejunectomy. The glucose effec-
tiveness was unaffected by the intestinal operations in
both GK and Wistar rats (Table 2). To confirm the validity
of the minimal model analysis, the SI values were regressed
against the respective values of the Matsuda-DeFronzo
index obtaining SI = 0.55 + 0.036 3 CISI (R = 0.69;
P , 0.0005).
We found no significant difference in the AUC of Ra,
normalized by VG, among the different operations (Table
2), suggesting that surgery did not affect glucose ab-
sorption. Using the VG value of Wistar rats (0.22 L/kg)
estimated by intravenous glucose tolerance test (34), we
found that the mean AUC of Ra per unit weight in our
data (38.9 mmol/L 3 0.22 L/kg = 8.56 mmol/kg) was
77.8% of the dose (11 mmol/kg), a percentage close to
that observed in humans (30).
Figure 4 shows the time course of the concentrations
of insulin and incretins (GLP-1 and GIP) during the OGTT.
The AUC for insulin (not reported) was significantly lower
in all surgical groups compared with nonoperated control
animals but no difference was found among the surgical
groups. Ileectomy and jejunectomy induced a greater GIP
response compared with sham-operation in Wistar rats.
GIP increased only after ileectomy in GK rats.
DISCUSSION
Exclusion of duodenum and jejunum from food transit
and, to a lesser extent, the removal of jejunum improved
whole-body SI in GK rats, as assessed by the minimal
model SI and the CISI index. SI values obtained by the
minimal model were consistent with the CISI values
calculated from the experimental OGTT data. The mini-
mal model analysis as a method for evaluating the glu-
cose disposal in rats is well-established in studies (34–37)
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in which SI was estimated by the intravenous glucose
tolerance test, resulting in values similar to those ob-
served in our investigation. Moreover, hepatic SI as cal-
culated by HOMA-IR improved in diabetic rats just a few
days after surgery, even in the presence of an increased
peripheral insulin resistance due to the surgical trauma.
The current study was specifically designed to in-
vestigate the role of distinct anatomic segments of the
small intestine in the regulation of SI. To minimize
confounding influence from weight loss and long periods
of improved metabolism, SI and glucose tolerance were
measured early after surgery.
Figure 2—Time course of body weight in Wistar (A) and GK (B) rats and time course of food intake in Wistar (C ) and GK (D) rats before
(day 0) and after surgery. Control, black circles; sham, open circles; ileectomy, black triangles; DJB, black squares; and jejunectomy,
open squares. Data are shown as means 6 SE (n = 6–10 for each group). Significances: weight, P < 0.01 control vs. surgical groups at
times from 1–10 days in both Wistar and GK rats; food intake, P < 0.001 control vs. surgical groups at times from 1–10 days in both
Wistar and GK rats (symbols omitted in the figure).
Table 1—Incremental AUC of glucose concentration, HOMA-IR index, and CISI
Indexes Control Sham Ileectomy DJB Jejunectomy
Wistar rats
DAUC(G) 3 1022 (mmol/L $ min) 2.54 6 0.72* 12.47 6 1.07 12.41 6 2.24 17.65 6 2.06* 6.33 6 1.97*
HOMA-IR 3 102 (mg $ dL21 $ mU $ mL21) 1.42 6 0.15 3.68 6 0.43 12.88 6 3.97* 5.80 6 1.06 4.32 6 0.66
CISI (mg $ dL21 $ mU $ mL21) 23.94 6 2.32* 12.76 6 1.30 7.36 6 1.51* 10.47 6 1.30 13.72 6 1.19
GK rats
DAUC(G) 3 1022 (mmol/L $ min) 12.60 6 1.14 14.86 6 1.16 11.50 6 7.73 9.47 6 3.12& 13.19 6 1.40
HOMA-IR 3 102 (mg $ dL21 $ mU $ mL21) 7.37 6 1.41* 30.87 6 1.43 30.36 6 9.84 18.39 6 2.22# 12.01 6 0.64*
CISI (mg $ dL21 $ mU $ mL21) 5.27 6 0.60* 2.48 6 0.10 3.82 6 0.49 5.83 6 0.72* 5.21 6 0.25*
Data are means 6 SD. DAUC(G), AUC of glucose concentration. Significant differences by ANOVA and Tukey test between sham and
the other groups: *P , 0.001; &P , 0.05; #P , 0.025.
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Our findings show that both resection and bypass of
segments of the proximal small bowel (but not distal
small bowel) improve SI in GK rats, a nonobese rodent
model of type 2 diabetes. This is consistent with the
proximal (foregut) hypothesis of diabetes control after
gastrointestinal bypass surgery. In the present in-
vestigation, the bypass of the duodenum and jejunum or
the resection of the jejunum did not change GLP-1 in
diabetic GK rats. The GIP response to the oral glucose
load was similarly unaffected by these procedures, sug-
gesting that, at least in these animals, the effect of these
operations is not mediated by changes in these incretins.
These results are consistent with those of at least two
recent studies (10,38) showing that GLP-1 levels are not
dramatically elevated shortly after DJB. This is in con-
trast with the evidence that RYGB and sleeve gastrec-
tomy result in rapid and large elevations of GLP-1 in
response to oral glucose or mixed-meal tests both in
humans and rodents. The discrepancy might be due to
the fact that RYGB and sleeve gastrectomy, unlike DJB,
involve significant manipulations of gastric anatomy. In
fact, a recent study (38) suggests that changes in GLP-1
response to nutrient stimuli may result from alterations
of gastric physiology rather than from intestinal rerout-
ing as previously believed.
The measurement of GLP-1 levels as early as 10 days
postoperatively might also explain why DJB did not af-
fect GLP-1 secretion in the current study. In fact, pre-
vious investigations in rodents suggest that elevation
of GLP-1 levels may be a late phenomenon after DJB
(13–15,39,40).
The rapid improvement of glucose homeostasis in
absence of substantial changes in GLP-1 secretion fol-
lowing DJB and jejunectomy in diabetic GK rats suggests
that mechanisms other than incretins may play a role in
the remission of diabetes after bariatric surgery. Other
recent investigations have similarly called into question
the role of GLP-1 in the improvement of glucose
Figure 3—Time course of blood glucose concentration in Wistar (A) and GK (B) rats. Control, black circles; sham, open circles; ileectomy,
black triangles; DJB, black squares; and jejunectomy, open squares. Data are shown as means 6 SE (n = 6–10 for each group). The lines
represent the optimal fitting obtained by the minimal model with the parameters in Table 2. Control, sham, and DJB, continuous lines;
ileectomy, dotted lines; and jejunectomy, dashed-dotted lines. Significance: *P< 0.001 control vs. sham; #P< 0.001 DJB vs. sham; +P<
0.05 control vs. sham; 3P < 0.001 ileectomy vs. sham; **P < 0.05 DJB vs. sham.
Table 2—Estimates of minimal model parameters and AUC of the ratio Ra/VG
Parameters Control Sham Ileectomy DJB Jejunectomy
Wistar rats
SG 3 10
2 (min21) 3.53 6 0.18 3.58 6 1.07 4.04 6 0.64 3.66 6 0.43 4.02 6 0.86
SI 3 10
4 (min21 $ pM21) 1.34 6 0.20* 1.01 6 0.06 0.84 6 0.09 1.21 6 0.18 1.03 6 0.17
p 3 102 (min21) 3.67 6 2.12 3.23 6 0.61 3.26 6 0.01 3.14 6 0.51 3.26 6 0.32
AUC (Ra/VG) 3 10
21 (mmol/L) 3.04 6 0.55 3.58 6 0.77 3.48 6 0.88 3.94 6 0.37 3.49 6 0.37
GK rats
SG 3 10
2 (min21) 3.32 6 0.75 3.64 6 0.33 3.29 6 1.01 3.66 6 0.31 3.65 6 0.36
SI 3 10
4 (min21 $ pM21) 0.40 6 0.11 0.60 6 0.16 0.53 6 0.21 1.14 6 0.32§ 0.80 6 0.14
p 3 102 (min21) 2.68 6 1.05 2.61 6 0.85 3.11 6 0.58 3.92 6 1.20 3.09 6 0.21
AUC (Ra/VG) 3 10
21 (mmol/L) 3.83 6 0.31 4.25 6 0.32 4.36 6 1.68 5.10 6 0.66 3.76 6 0.81
Data are means 6 SD. Significant differences by ANOVA and Tukey test between sham and the other groups: *P , 0.01; §P , 0.001.
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tolerance after gastrointestinal surgery. In fact, the
effects of sleeve gastrectomy on body weight and glucose
tolerance are substantially preserved in GLP-1 receptor–
deficient mice (41), and infusion of a GLP-1 receptor
antagonist after RYGB does not reverse improvements in
diabetes or glucose tolerance in humans (42). The results
of our study also show that DJB and jejunectomy im-
prove whole-body SI only in diabetic GK rats but not in
normal Wistar rats, confirming earlier findings that DJB
improves oral glucose tolerance in diabetic but not in
glucose-tolerant animals (4). Taken together with the
evidence that improved SI after DJB and jejunectomy was
Figure 4—Time course of plasma insulin concentration in Wistar (A) and GK (B) rats, active GLP-1 concentration in Wistar (C) and GK (D)
rats, and GIP concentration in Wistar (E) and GK (F) rats. Control, black circles; sham, open circles; ileectomy, black triangles; DJB, black
squares; and jejunectomy, open squares. Data are shown as means 6 SE (n = 6–10 for each group). Significances are as follows. Insulin:
*P < 0.005 control vs. all other groups; 3P < 0.005 control vs. ileectomy; +P < 0.05 control vs. DJB and ileectomy; #P < 0.05 control vs.
sham, DJB, and jejunectomy; **P < 0.05 control vs. all other groups. GIP Wistar rats: *P < 0.001 ileectomy vs. sham, **P < 0.05 DJB vs.
sham; +P < 0.05 ileectomy vs. sham; 3P < 0.05 ileectomy vs. control and sham. GIP GK rats: *P < 0.001 ileectomy vs. all other groups;
#P < 0.01 ileectomy vs. control, sham, and DJB.
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not associated with changes in GLP-1, GIP, or insulin,
these findings support the hypothesis that bypass or
resection of proximal segments of the small intestine
might reduce or remove factor(s) that inhibit SI (3,4).
Furthermore, the fact that DJB and jejunectomy, but not
ileal resection, improved SI suggests that such putative
factors may be located in or regulated by the proximal
small intestine (duodenum and jejunum).
The question remains whether the primary site
contributing to insulin resistance is the duodenum, je-
junum, or both. The ability of jejunectomy to improve SI
in this study, as well as the reported improvement of
diabetes after intestinal procedures that maintain duo-
denal passage of nutrients such as the jejuno-ileal by-
pass (20), would suggest a major role of the jejunum. In
contrast, however, RYGB, DJB, and endoluminal duo-
denal sleeve bypass the entire duodenum and only
a small segment of the proximal jejunum (12). The an-
atomic distinction between duodenum and jejunum is
rather arbitrary, and most physiologic mechanisms of
the intestinal mucosa show a typical proximal-to-distal
(or vice versa) gradient. Hence, if the proximal small
intestine of diabetic subjects produces or regulates
factor(s) that inhibit SI as suggested by this study, it is
likely that this occurs according to a similar gradient
rather than as a phenomenon restricted to an exact
anatomic segment of the bowel. Accordingly, the control
of diabetes after gastrointestinal bypass surgery may
derive from the exclusion of both duodenum and jeju-
num, and procedures that bypass the entire length of
the proximal small bowel may have more powerful
effects on SI than those with shorter lengths of in-
testinal bypass. Consistent with this hypothesis is the
fact that bilio-pancreatic diversion (BPD), an operation
that involves the greatest length of intestinal bypass
(the duodenum and jejunum in their entirety) is asso-
ciated with the best rates of long-term remission of
diabetes (5,12). BPD results in major improvement of
skeletal muscle SI, mediated by changes in the expres-
sion of genes that regulate glucose and fatty acid me-
tabolism in response to nutrient availability (43).
The anti-incretin theory (3,4,25,44) posits the exis-
tence of nutrients-stimulated mechanisms originating
in or regulated by the proximal small bowel with the
physiological role of preventing postprandial hypogly-
cemia from incretin-induced insulin secretion. Dys-
functional gastrointestinal physiology resulting in the
disproportionate enhancement of anti-incretin mecha-
nisms would result in insulin resistance and/or defects
in insulin production predisposing to type 2 diabetes.
Accordingly, a bypass of the proximal intestine (i.e.,
after RYGB, BPD, or DJB) could re-establish a physio-
logic balance between incretin and anti-incretin signals,
thus restoring normal glycemic excursions. The anti-
incretin theory predicts that intestinal bypass proce-
dures (or resection of small bowel segments) would only
improve glucose homeostasis in subjects with glucose
intolerance/diabetes but not in normotolerant individ-
uals. This is consistent with the observation that DJB
and jejunectomy in this study only improved SI in
diabetic rats but not in normal animals. Further ex-
perimental evidence in support of the anti-incretin
theory derives from findings that proteins secreted by
the duodenum/jejunum of diabetic db/db mice or
insulin-resistant humans can induce insulin resistance
both in vivo (in Swiss mice) and in vitro (myocytes
cultures) (45).
We acknowledge several limitations of our study.
First, our experiments did not investigate the exact
molecular mechanisms behind the improvement of SI
after DJB or jejunectomy; our findings only allow us to
exclude GLP-1 and GIP as factors. Furthermore, ana-
tomic manipulations of the intestine induce adaptive
intestinal responses that can influence energy homeo-
stasis. Measuring SI at a single time point, as we did in
this study, may therefore depend on adaptive phenom-
ena and not accurately reflect the steady state. As shown
by Ljungmann et al. (46), however, rats that undergo
resection of even 80% of the small bowel regain most of
their body weight within 10 days from the operation,
while most of the adaptive response of the residual small
intestine occurs during the first week after surgery. Since
we investigated glucose disposal 10 days after the oper-
ation, our findings should reflect a state after intestinal
adaptation and weight recovery have already occurred.
Also, our study investigated only the early effects of in-
testinal manipulations on insulin resistance and was not
designed to assess potential clinical effectiveness of new
procedures; hence, in no way do we propose jejunectomy
as a possible operation in humans.
In conclusion, SI improved in diabetic rats after both
DJB and resection of the jejunum without changes in
circulating incretin levels. These findings suggest a pos-
sible role of the proximal small bowel in the patho-
physiology of insulin resistance and its improvement
after gastrointestinal operations.
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